Advertisement
Screener

EQUILLIUM, INC. (EQ) OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax

1.8 / 5 stars · 16/45 Roast Me

EQUILLIUM, INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax

EQUILLIUM, INC. (EQ) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Other Income

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax · last filed 2026-08-13

  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2026-06-30 was $0.00.
  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-12-31 was $0.00.
  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-06-30 was $0.00.
  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2025 was -$3.00K.
  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2024 was -$15.00K, a 113.89% decline from fiscal 2023.
  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2023 was $108.00K.
  • EQUILLIUM, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2022 was -$38.00K.
Period endOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 3 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 9 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 12 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 12 month as first filed
2026-06-30$0.00
10-Q · filed 2026-08-13
$0.00
10-Q · filed 2026-08-13
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$0.00
derived: sum of 2 quarters · filed 2026-03-25
$0.00
derived: sum of 3 quarters · filed 2026-08-13
-$3.00K
10-K · filed 2026-03-25
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$0.00
derived: sum of 2 quarters · filed 2026-08-13
-$3.00K
10-Q · filed 2025-11-13
-$12.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$0.00
10-Q · filed 2026-08-13
-$3.00K
10-Q · filed 2026-08-13
-$12.00K
derived: sum of 3 quarters · filed 2026-08-13
$9.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$3.00K
10-Q · filed 2026-05-13
-$12.00K
derived: sum of 2 quarters · filed 2026-05-13
$9.00K
derived: sum of 3 quarters · filed 2026-05-13
$3.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$9.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$12.00K
derived: sum of 2 quarters · filed 2026-03-25
$6.00K
derived: sum of 3 quarters · filed 2026-03-25
-$15.00K
10-K · filed 2026-03-25
2024-09-30$21.00K
10-Q · filed 2025-11-13
$15.00K
derived: sum of 2 quarters · filed 2025-11-13
-$6.00K
10-Q · filed 2025-11-13
$23.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$6.00K
10-Q · filed 2025-08-14
-$28.00K
10-Q · filed 2025-08-14
$2.00K
derived: sum of 3 quarters · filed 2025-08-14
$21.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$22.00K
10-Q · filed 2025-05-14
$8.00K
derived: sum of 2 quarters · filed 2025-05-14
$27.00K
derived: sum of 3 quarters · filed 2025-05-14
-$9.00K
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$49.00K
derived: sum of 2 quarters · filed 2025-03-27
$13.00K
derived: sum of 3 quarters · filed 2025-03-27
$108.00K
10-K · filed 2025-03-27
2023-09-30$19.00K
10-Q · filed 2024-11-13
-$17.00K
derived: sum of 2 quarters · filed 2024-11-13
$78.00K
10-Q · filed 2024-11-13
$206.00K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$36.00K
10-Q · filed 2024-08-08
$59.00K
10-Q · filed 2024-08-08
$187.00K
derived: sum of 3 quarters · filed 2024-08-08
$256.00K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$96.00K
10-Q · filed 2024-05-09
$223.00K
derived: sum of 2 quarters · filed 2024-05-09
$292.00K
derived: sum of 3 quarters · filed 2024-05-09
$238.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$127.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
$196.00K
derived: sum of 2 quarters · filed 2024-03-25
$142.00K
derived: sum of 3 quarters · filed 2024-03-25
-$38.00K
10-K · filed 2024-03-25
2022-09-30$69.00K
10-Q · filed 2023-11-08
$15.00K
derived: sum of 2 quarters · filed 2023-11-08
-$165.00K
10-Q · filed 2023-11-08
-$213.00K
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$54.00K
10-Q · filed 2023-08-09
-$234.00K
10-Q · filed 2023-08-09
-$282.00K
derived: sum of 3 quarters · filed 2023-08-09
-$285.00K
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31-$180.00K
10-Q · filed 2023-05-11
-$228.00K
derived: sum of 2 quarters · filed 2023-05-11
-$231.00K
derived: sum of 3 quarters · filed 2023-05-11
-$236.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$48.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
-$51.00K
derived: sum of 2 quarters · filed 2023-03-23
-$56.00K
derived: sum of 3 quarters · filed 2023-03-23
-$59.00K
10-K · filed 2023-03-23
2021-09-30-$3.00K
10-Q · filed 2022-11-14
-$8.00K
derived: sum of 2 quarters · filed 2022-11-14
-$11.00K
10-Q · filed 2022-11-14
-$50.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$5.00K
10-Q · filed 2022-08-15
-$8.00K
10-Q · filed 2022-08-15
-$47.00K
derived: sum of 3 quarters · filed 2022-08-15
-$118.00K
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$3.00K
10-Q · filed 2022-05-12
-$42.00K
derived: sum of 2 quarters · filed 2022-05-12
-$113.00K
derived: sum of 3 quarters · filed 2022-05-12
-$182.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$39.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
-$110.00K
derived: sum of 2 quarters · filed 2022-03-23
-$179.00K
derived: sum of 3 quarters · filed 2022-03-23
-$41.00K
10-K · filed 2022-03-23
2020-09-30-$71.00K
10-Q · filed 2021-11-10
-$140.00K
derived: sum of 2 quarters · filed 2021-11-10
-$2.00K
10-Q · filed 2021-11-10
-$27.00K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$69.00K
10-Q · filed 2021-08-10
$69.00K
10-Q · filed 2021-08-10
$44.00K
derived: sum of 3 quarters · filed 2021-08-10
$30.00K
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$138.00K
10-Q · filed 2021-05-13
$113.00K
derived: sum of 2 quarters · filed 2021-05-13
$99.00K
derived: sum of 3 quarters · filed 2021-05-13
$138.00K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24
-$39.00K
derived: sum of 2 quarters · filed 2021-03-24
$0.00
derived: sum of 3 quarters · filed 2021-03-24
$44.00K
10-K · filed 2021-03-24
2019-09-30-$14.00K
10-Q · filed 2020-11-10
$25.00K
derived: sum of 2 quarters · filed 2020-11-10
$69.00K
10-Q · filed 2020-11-10
2019-06-30$39.00K
10-Q · filed 2020-08-12
$83.00K
10-Q · filed 2020-08-12
2019-03-31$44.00K
10-Q · filed 2020-05-13
2018-12-31$5.00K
10-K · filed 2020-03-26
$5.28K
10-K · filed 2019-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
GENELUX Corp (GNLX)United States$0.110B-3.83
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
ProMIS Neurosciences Inc. (PMN)$0.102B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49